126 related articles for article (PubMed ID: 36576398)
1. Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia.
Chen Y; Shao X; Yang H; Ren L; Cui Y; Zhang W; Macip S; Meng X
Eur J Haematol; 2023 Apr; 110(4):435-443. PubMed ID: 36576398
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ enhances CLL cell resistance to ABT-199 by regulating MCL-1 and BCL-2 expression via the JAK-STAT3 signaling pathway.
Shao X; Meng X; Yang H; Wang X; Qin L; Shen G; Xi X; Zhao H; Macip S; Chen Y
Leuk Lymphoma; 2023 Jan; 64(1):71-78. PubMed ID: 36222521
[TBL] [Abstract][Full Text] [Related]
4. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells.
Jurlander J; Lai CF; Tan J; Chou CC; Geisler CH; Schriber J; Blumenson LE; Narula SK; Baumann H; Caligiuri MA
Blood; 1997 Jun; 89(11):4146-52. PubMed ID: 9166857
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.
Rozovski U; Wu JY; Harris DM; Liu Z; Li P; Hazan-Halevy I; Ferrajoli A; Burger JA; O'Brien S; Jain N; Verstovsek S; Wierda WG; Keating MJ; Estrov Z
Blood; 2014 Jun; 123(24):3797-802. PubMed ID: 24778152
[TBL] [Abstract][Full Text] [Related]
6. STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1.
Battle TE; Frank DA
Blood; 2003 Oct; 102(8):3016-24. PubMed ID: 12855573
[TBL] [Abstract][Full Text] [Related]
7. Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway.
Bauvois B; Pramil E; Jondreville L; Quiney C; Nguyen-Khac F; Susin SA
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33668421
[TBL] [Abstract][Full Text] [Related]
8. Isoliquiritigenin Inhibits Interferon-γ-Inducible Genes Expression in Hepatocytes through Down-Regulating Activation of JAK1/STAT1, IRF3/MyD88, ERK/MAPK, JNK/MAPK and PI3K/Akt Signaling Pathways.
Wu S; Xue J; Yang Y; Zhu H; Chen F; Wang J; Lou G; Liu Y; Shi Y; Yu Y; Xia C; Hu Y; Chen Z
Cell Physiol Biochem; 2015; 37(2):501-14. PubMed ID: 26315837
[TBL] [Abstract][Full Text] [Related]
9. Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
Int J Cancer; 2017 Nov; 141(10):2076-2081. PubMed ID: 28722170
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation.
Bai Y; Ahmad U; Wang Y; Li JH; Choy JC; Kim RW; Kirkiles-Smith N; Maher SE; Karras JG; Bennett CF; Bothwell AL; Pober JS; Tellides G
J Biol Chem; 2008 Mar; 283(11):6832-42. PubMed ID: 18192275
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism.
Bürgler S; Gimeno A; Parente-Ribes A; Wang D; Os A; Devereux S; Jebsen P; Bogen B; Tjønnfjord GE; Munthe LA
J Immunol; 2015 Jan; 194(2):827-35. PubMed ID: 25505279
[TBL] [Abstract][Full Text] [Related]
12. STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.
Liu FT; Jia L; Wang P; Wang H; Farren TW; Agrawal SG
Oncotarget; 2016 May; 7(22):32031-45. PubMed ID: 27074565
[TBL] [Abstract][Full Text] [Related]
13. Increased autocrine interleukin-6 production is significantly associated with worse clinical outcome in patients with chronic lymphocytic leukemia.
Wang HQ; Jia L; Li YT; Farren T; Agrawal SG; Liu FT
J Cell Physiol; 2019 Aug; 234(8):13994-14006. PubMed ID: 30623437
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
[TBL] [Abstract][Full Text] [Related]
15. Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia.
Tomic J; Lichty B; Spaner DE
Blood; 2011 Mar; 117(9):2668-80. PubMed ID: 21205928
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
Fang P; Hwa V; Rosenfeld RG
Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044
[TBL] [Abstract][Full Text] [Related]
17. Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells.
Rozovski U; Calin GA; Setoyama T; D'Abundo L; Harris DM; Li P; Liu Z; Grgurevic S; Ferrajoli A; Faderl S; Burger JA; O'Brien S; Wierda WG; Keating MJ; Estrov Z
Mol Cancer; 2013 Jun; 12():50. PubMed ID: 23725032
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli.
Hosui A; Ohkawa K; Ishida H; Sato A; Nakanishi F; Ueda K; Takehara T; Kasahara A; Sasaki Y; Hori M; Hayashi N
J Biol Chem; 2003 Aug; 278(31):28562-71. PubMed ID: 12764155
[TBL] [Abstract][Full Text] [Related]
20. The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology.
Boudny M; Trbusek M
Klin Onkol; 2020; 33(1):32-38. PubMed ID: 32075387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
